- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Publication
Article
Dermatology Times
AIVITA Biomedical names new CFO, VP of business development
Author(s):
AIVITA Biomedical, a biotech firm that focuses on regenerative medicines such as stem cell applications, recently named two new members to its senior management team.
Mr. Burrell
Mr. Green
AIVITA Biomedical, a biotech firm that focuses on regenerative medicines such as stem cell applications, recently named two new members to its senior management team, according to a company news release.
New chief financial officer Scott Burrell joined from CombiMatrix Corporation, where he also was CFO and helped manage that company’s sale. His background includes 25 years in corporate finance and compliance, working in healthcare, high-tech and biotech fields.
Kevin Green was named AIVITA’s vice president of business development. For 10 years at Allergan, he was senior director of business development, overseeing transactions, including the $2.1 billion Kythera acquisition.
“Mr. Burrell and Mr. Green bring decades of B2B, corporate finance and capital raising experience to AIVITA. These appointments reflect our plans for further capitalization via investment and partnership,” AIVITA Chairman and CEO Hans S. Keirstead, Ph.D., said in a news release.
AIVITA, a privately-held company, also recently made hires to support its ROOT OF SKIN and ROOT OF SKIN MD skincare lines.
